CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 180 participants.

Also called NCT02816762

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 180 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02816762
Other papers using this trial's data
  • Continuous Positive Airway Pressure Effect on Albuminuria Progression in Patients with Obstructive Sleep Apnea and Diabetic Kidney Disease: A Randomized Clinical Trial American journal of respiratory and critical care medicine, 2023-03-15 DOI, PubMed 36342964

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02816762. Randomized; no masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2020-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CPAP Effect on Albuminuria in Patients With Diabetic Nephropathy and Obstructive Sleep Apnea
Acronym
DIANA
Condition
Diabetic Nephropathy
Condition
Sleep Apnea
Intervention (Device)
Continuous positive airway pressure
Intervention (Drug)
Pharmacological treatment
Intervention (Other)
Diet
Lead sponsor
Hospital Universitario La Paz (class: other)

Record details

Record id
cardio:ct-nct02816762
Content hash
ad73af1f99d8f3217f812ae1fcb5c1a3a0ef684540bce7dd986f573af955a5a9